slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 25,861-25,890
Pages 1,935
Rows per page 30
Slide function
25,861-25,890 of 58,039
13
The table includes both reported and organic change metrics for three-month and nine-month periods ending September 30, 2021.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
18
The table reconciles Net Income to Adjusted EBITDA by adding back taxes, D&A, and adjusting for impairments, acquisition costs, and share-based compensation.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
19
The table provides a detailed breakdown of adjustments including exchange rates, divestitures, and discontinuations to arrive at organic revenue figures.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
20
The table adjusts reported revenue for changes in exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
21
The table reconciles GAAP operating cash flow to a non-GAAP adjusted figure by adding/subtracting specific items like legal settlements, separation costs, and Amoun operating activities.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
The table provides a detailed breakdown of adjustments including impairments, restructuring, and litigation costs.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
07
The table includes both reported and organic growth metrics, with footnotes detailing non-GAAP adjustments and segment realignments.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
Includes both GAAP and non-GAAP financial measures with variance analysis.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
Includes a callout box highlighting specific GAAP and non-GAAP cash flow figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
Includes footnotes detailing specific debt adjustments and divestiture impacts.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Includes detailed assumptions for expenses, tax rates, share counts, and cash items.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
16
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
20
The slide uses a mix of bar charts and line charts with trend lines to illustrate recovery.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
22
The slide uses trend lines to highlight recovery and strong performance across three distinct product lines.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
23
Includes a map-based visualization of regional product performance and a donut chart for revenue breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
24
Includes CAGR annotations on bar charts.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
36
The slide details the financial impact of segment realignments, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks financial performance changes for specific product lines following patent expirations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
LOE stands for Loss of Exclusivity. The table tracks financial variance between two forecast periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
The table compares inventory levels across two years, highlighting the change in months on hand for each business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
The table highlights inventory levels for specific business units, showing an increase in months on hand across all units in the 2021 period compared to 2020.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The slide highlights a 6% organic revenue growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
Includes detailed footnotes regarding non-GAAP adjustments and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics and segment-specific growth rates.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit